1. PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells

   • Sarah Thomas Broome
   • Giuseppe Musumeci
   • Alessandro Castorina

   OriginalPaper Open access 24 February 2022 Pages: 2163 - 2175

   

2. Distribution of PACAP and PAC1 Receptor in the Human Eye

   • Evelin Patko
   • Edina Szabo
   • Dora Reglodi

   OriginalPaper Open access 07 March 2022 Pages: 2176 - 2187

   

3. Particulate Matters Affecting lncRNA Dysregulation and Glioblastoma Invasiveness: In Silico Applications and Current Insights

   • Swagatama Mukherjee
   • Uma Kundu
   • Prakash P. Pillai

   ReviewPaper 12 November 2022 Pages: 2188 - 2206

   

4. Associations of Reported Genetic Risk Loci with Sporadic Brain Arteriovenous Malformations: Meta-analysis

   • Kymbat Mukhtarova
   • Elena Zholdybayeva
   • Yerlan Ramankulov

   OriginalPaper 09 October 2022 Pages: 2207 - 2217

   

5. AATF Competitively Interacts with Nuclear AIF and Inhibits Parthanatos of Neurons in dMCAO/R and OGD/R Models

   • Wei Xu
   • Zhen Hu
   • Chuan-cheng Ren

   OriginalPaper 05 September 2022 Pages: 2218 - 2232

   

6. Prenatal Methamphetamine Hydrochloride Exposure Leads to Signal Transduction Alteration and Cell Death in the Prefrontal Cortex and Amygdala of Male and Female Rats’ Offspring

   • Nayereh Zare
   • Nader Maghsoudi
   • Batool Ghorbani Yekta

   OriginalPaper 03 September 2022 Pages: 2233 - 2241

   

7. Expanding the Phenotypic Spectrum of APMR4 Syndrome Caused by a Novel Variant in LSS Gene and Review of Literature

   • Nesma M. Elaraby
   • Hoda A. Ahmed
   • Engy A. Ashaat

   OriginalPaper Open access 17 October 2022 Pages: 2242 - 2251

   

8. Molecular Dynamic Simulation of Neurexin1α Mutations Associated with Mental Disorder

   • Ashraf Hendam
   • Ahmed Farouk Al-Sadek
   • Hesham Ahmed Hefny

   OriginalPaper 05 October 2022 Pages: 2252 - 2272

   

9. Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer’s Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation

   • Saeid Bagheri-Mohammadi
   • Sahar Askari
   • Rasoul Ghasemi

   OriginalPaper 10 October 2022 Pages: 2273 - 2291

   

10. Cerebrolysin Alleviating Effect on Glutamate-Mediated Neuroinflammation Via Glutamate Transporters and Oxidative Stress

    • Seydanur Avci
    • Sukran Gunaydin
    • Ali Taghizadehghalehjoughi

    OriginalPaper 04 November 2022 Pages: 2292 - 2302

    

11. Assessment of Serum Hypoxia Biomarkers Pre- and Post-radiotherapy in Patients with Brain Tumors

    • Sanaa A. El-Benhawy
    • Ola A. Sakr
    • Sherif Elzawawy

    OriginalPaper Open access 19 September 2022 Pages: 2303 - 2312

12. Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes

    • Rika Kojima
    • Mark Zurbruegg
    • Per Svenningsson

    OriginalPaper Open access 24 September 2022 Pages: 2313 - 2325

    

13. Discovering Common Pathogenic Mechanisms of COVID-19 and Parkinson Disease: An Integrated Bioinformatics Analysis

    • Aria Jahanimoghadam
    • Hadis Abdolahzadeh
    • Javad Zahiri

    OriginalPaper 27 October 2022 Pages: 2326 - 2337

    

14. Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant Carriers

    • Danial Kazemi
    • Hamed Hajishah
    • Amir Shayan Chadeganipour

    OriginalPaper 20 September 2022 Pages: 2338 - 2344

15. Cerebral Small Vessel Disease: A Bibliometric Analysis

    • Wei Ma
    • Yi-Bao Yang
    • Xue-Ni Mo

    OriginalPaper Open access 06 October 2022 Pages: 2345 - 2359

    

16. Integrative Analysis of Motor Neuron and Microglial Transcriptomes from SOD1^G93A Mice Models Uncover Potential Drug Treatments for ALS

    • Elif Kubat Oktem
    • Busra Aydin
    • Kazim Yalcin Arga

    OriginalPaper 30 September 2022 Pages: 2360 - 2376